118 related articles for article (PubMed ID: 20508271)
1. Enteroviral encephalitis in a patient with a marginal zone lymphomatreated with rituximab.
Schilthuizen C; Berenschot HW; Levin MD
Neth J Med; 2010 May; 68(5):221-3. PubMed ID: 20508271
[TBL] [Abstract][Full Text] [Related]
2. Enteroviral meningoencephalitis in a patient with non-Hodgkin's lymphoma treated previously with rituximab.
Padate BP; Keidan J
Clin Lab Haematol; 2006 Feb; 28(1):69-71. PubMed ID: 16430465
[TBL] [Abstract][Full Text] [Related]
3. Enteroviral meningoencephalitis as complication of Rituximab therapy in a patient treated for diffuse large B-cell lymphoma.
Servais S; Caers J; Warling O; Frusch N; Baron F; De Prijck B; Beguin Y
Br J Haematol; 2010 Aug; 150(3):379-81. PubMed ID: 20408837
[No Abstract] [Full Text] [Related]
4. [Serum sickness induced by rituximab infusion; report of two cases with hematological malignancies].
Matsui T; Hidaka M; Kawakita T; Inoue Y; Sakai T; Harada N; Takemoto S; Nagakura S; Tsukamoto A; Kiyokawa T; Kawano F
Rinsho Ketsueki; 2009 Apr; 50(4):304-8. PubMed ID: 19404025
[TBL] [Abstract][Full Text] [Related]
5. Clinical application of reverse-transcription polymerase chain reaction and intravenous immunoglobulin for enterovirus encephalitis.
Cheng MF; Chen BC; Huang TS; Hsieh KS; Chen SN; Liu YC
Jpn J Infect Dis; 2008 Jan; 61(1):18-24. PubMed ID: 18219129
[TBL] [Abstract][Full Text] [Related]
6. Enteroviral Encephalitis in a Child With CNS Relapse of Burkitt Leukemia Treated With Rituximab.
Shaheen N; Mussai F
J Pediatr Hematol Oncol; 2019 Jan; 41(1):e27-e29. PubMed ID: 29315142
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of rituximab-containing regimens on indolent B-cell lymphoma--a report of 34 cases].
Xia ZJ; Wang FH; Huang HQ; Luo HY; Li YH; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):490-4. PubMed ID: 16613687
[TBL] [Abstract][Full Text] [Related]
8. Normalization of anticardiolipin antibodies following rituximab therapy for marginal zone lymphoma in a patient with Sjogren's syndrome.
Harner KC; Jackson LW; Drabick JJ
Rheumatology (Oxford); 2004 Oct; 43(10):1309-10. PubMed ID: 15448217
[No Abstract] [Full Text] [Related]
9. Successful treatment with a rituximab-based regimen of a splenic marginal zone lymphoma with villous lymphocytes in a very frail patient on maintenance dialysis.
Niscola P; Palumbo R; Scaramucci L; Tendas A; Cupelli L; Giovannini M; Piccioni D; Dentamaro T; Perrotti AP; de Fabritiis P
Cancer Chemother Pharmacol; 2009 Mar; 63(4):759-60. PubMed ID: 18500519
[No Abstract] [Full Text] [Related]
10. Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy.
Isobe Y; Sugimoto K; Shiraki Y; Nishitani M; Koike K; Oshimi K
Am J Hematol; 2004 Dec; 77(4):370-3. PubMed ID: 15558805
[TBL] [Abstract][Full Text] [Related]
11. Edema of the eyelids and sclera after rituximab infusion for orbital MALT lymphoma.
Oribe N; Tanimoto TE; Shimoda K; Hikiji W; Mitsugi K; Takase K; Henzan H; Numata A; Miyamoto T; Fukuda T; Nagafuji K; Harada M
Haematologica; 2004 Jun; 89(6 Suppl):EIM14. PubMed ID: 15194556
[No Abstract] [Full Text] [Related]
12. [Enteroviral infections in adults treated with rituximab: A new case of chronic meningitis and myofasciitis and literature review].
Maillet F; Pineton De Chambrun M; Monzani Q; Mercy G; Schuffenecker I; Mirand A; Deback C; Charlotte F; Fourniols E; Mathian A; Amoura Z
Rev Med Interne; 2020 Mar; 41(3):200-205. PubMed ID: 31980187
[TBL] [Abstract][Full Text] [Related]
13. Changes in salivary gland immunohistology and function after rituximab monotherapy in a patient with Sjogren's syndrome and associated MALT lymphoma.
Pijpe J; van Imhoff GW; Vissink A; van der Wal JE; Kluin PM; Spijkervet FK; Kallenberg CG; Bootsma H
Ann Rheum Dis; 2005 Jun; 64(6):958-60. PubMed ID: 15576414
[TBL] [Abstract][Full Text] [Related]
14. Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula.
Fattal-Valevski A; Kesler A; Sela BA; Nitzan-Kaluski D; Rotstein M; Mesterman R; Toledano-Alhadef H; Stolovitch C; Hoffmann C; Globus O; Eshel G
Pediatrics; 2005 Feb; 115(2):e233-8. PubMed ID: 15687431
[TBL] [Abstract][Full Text] [Related]
15. Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy.
Martinelli G; Laszlo D; Ferreri AJ; Pruneri G; Ponzoni M; Conconi A; Crosta C; Pedrinis E; Bertoni F; Calabrese L; Zucca E
J Clin Oncol; 2005 Mar; 23(9):1979-83. PubMed ID: 15668468
[TBL] [Abstract][Full Text] [Related]
16. [A case of primary mucosa-associated lymphoid tissue lymphoma of the bladder regressed after rituximab in combination with CHOP chemotherapy].
Kakuta Y; Katoh T; Saitoh J; Yazawa K; Hosomi M; Itoh K
Hinyokika Kiyo; 2006 Dec; 52(12):951-4. PubMed ID: 17252980
[TBL] [Abstract][Full Text] [Related]
17. Does rituximab aggravate pre-existing hypogammaglobulinaemia?
Diwakar L; Gorrie S; Richter A; Chapman O; Dhillon P; Al-Ghanmi F; Noorani S; Krishna MT; Huissoon A
J Clin Pathol; 2010 Mar; 63(3):275-7. PubMed ID: 20203231
[TBL] [Abstract][Full Text] [Related]
18. Treatment of splenic marginal zone lymphoma: splenectomy versus rituximab.
Bennett M; Schechter GP
Semin Hematol; 2010 Apr; 47(2):143-7. PubMed ID: 20350661
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type.
Salar A; Domingo-Domenech E; Estany C; Canales MA; Gallardo F; Servitje O; Fraile G; Montalbán C
Cancer; 2009 Nov; 115(22):5210-7. PubMed ID: 19672998
[TBL] [Abstract][Full Text] [Related]
20. Eight-cycle rituximab therapy resulted in complete remission in primary cutaneous marginal zone lymphoma.
Seker M; Ustaalioğlu BB; Bilici A; Yildirim ME; Kefeli U; Barisik NO; Tamer I; Gumus M
Leuk Res; 2010 Jul; 34(7):e160-3. PubMed ID: 20219245
[No Abstract] [Full Text] [Related]
[Next] [New Search]
